Upfront treatment of high-risk neuroblastoma with a combination of131I-MIBG and topotecan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upfront treatment of high-risk neuroblastoma with a combination of131I-MIBG and topotecan

Published:2015-05-15 Issue:11 Volume:62 Page:1886-1891
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Kraal Kathelijne C.J.M.¹²,Tytgat Godelieve A.M.¹,van Eck-Smit Berthe L.F.³,Kam Boen⁴,Caron Huib N.¹,van Noesel Max²⁵

Affiliation:

1. Department of Pediatric Oncology; Amsterdam Medical Centre (AMC); Amsterdam the Netherlands

2. Princess Máxima Centre for Pediatric Oncology; Utrecht the Netherlands

3. Department of Nuclear Medicine; Amsterdam Medical Centre (AMC); Amsterdam the Netherlands

4. Department of Nuclear Medicine; Erasmus MC-Sophia Children's Hospital; Rotterdam the Netherlands

5. Department of Pediatric Oncology/Hematology; Erasmus MC-Sophia Children's Hospital; Rotterdam the Netherlands

Funder

Stichting Kinderen kanker Vrij (KIKA)

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

2. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial;Pearson;Lancet Oncol,2008

3. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage;Brodeur;Science,1984

4. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010

5. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma;de Kraker;Eur J Cancer,1995

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma;EJNMMI Research;2024-06-13

2. Advances in Radioligand Theranostics in Oncology;Molecular Diagnosis & Therapy;2024-03-31

3. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma;2024-01-18

4. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10

5. Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient;Frontiers in Oncology;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3